Frequency of Immune Checkpoint Inhibitor-Induced Vasculitides: An Observational Study Using Data From the Japanese Adverse Drug Event Report Database
Information on immune checkpoint inhibitor-induced vasculitides is limited, and predictors for this condition have not been identified. Therefore, we have examined the frequency of immune checkpoint inhibitor-induced vasculitides by analyzing the data recorded in the Japanese Adverse Drug Event Repo...
Main Authors: | Koki Kato, Tomohiro Mizuno, Takenao Koseki, Yoshimasa Ito, Kazuo Takahashi, Naotake Tsuboi, Shigeki Yamada |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.803706/full |
Similar Items
-
The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
by: Jacob Venborg, et al.
Published: (2021-11-01) -
Did the first description of patients with polymyalgia rheumatica take place in Scotland or in Denmark?
by: C. Manzo, et al.
Published: (2024-03-01) -
Dietary Implications of the Bidirectional Relationship between the Gut Microflora and Inflammatory Diseases with Special Emphasis on Irritable Bowel Disease: Current and Future Perspective
by: Tariq Aziz, et al.
Published: (2023-06-01) -
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab
by: F.M. Perrotta, et al.
Published: (2020-11-01) -
Combining immune‐checkpoint inhibitors with tocilizumab to treat a lung adenocarcinoma patient with pre‐existing polymyalgia rheumatica: A case report
by: Yang Du, et al.
Published: (2024-01-01)